Award recordCONTRACT

TRIAD ISOTOPES, INC.

PIID VA25613P0846· VHA· 256-NETWORK CONTRACT OFFICE 16· 6505 · DRUGS AND BIOLOGICALS· FY2013· $274,733 net obligations· UEI NRMNYAAVZ767· FL

Description

RADIOPHARMACEUTICALS FOR THE BILOXI VA AND THE PENSACOLA JACC INCREASE FUNDS IN ORDER TO PAY FINAL INVOICES (520C40094)

Base award description: RADIOPHARMACEUTICALS FOR THE BILOXI VA AND THE PENSACOLA JACC

First action · last action
2013-04-01 · 2014-09-22
Transactions
9
First transaction's obligation
$92,265
Base + all options value (sum of deltas)
$274,733
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
AUTHORIZED BY STATUTE
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 9 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$274,733$0Base award · 2013-04-01 · this action $92,265 · running total $92,265Modification P00001 · 2013-04-23 · this action $0 · running total $92,265Modification P00002 · 2013-05-31 · this action $90,632 · running total $182,897Modification P00003 · 2013-10-01 · this action $60,000 · running total $242,897Modification P00004 · 2014-02-05 · this action $11,277 · running total $254,175Modification P00005 · 2014-02-13 · this action $3,980 · running total $258,154Modification P00006 · 2014-05-08 · this action -$93 · running total $258,061Modification P00007 · 2014-05-16 · this action $15,663 · running total $273,724Modification P00008 · 2014-09-22 · this action $1,009 · running total $274,733
  • Base2013-04-01+$92,265= $92,265
  • Mod P000012013-04-23+$0= $92,265
  • Mod P000022013-05-31+$90,632= $182,897
  • Mod P000032013-10-01+$60,000= $242,897
  • Mod P000042014-02-05+$11,277= $254,175
  • Mod P000052014-02-13+$3,980= $258,154
  • Mod P000062014-05-08-$93= $258,061
  • Mod P000072014-05-16+$15,663= $273,724
  • Mod P000082014-09-22+$1,009= $274,733
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2013-04-01+$92,265$92,265RADIOPHARMACEUTICALS FOR THE BILOXI VA AND THE PENSACOLA JACC
Mod P00001· OTHER ADMINISTRATIVE ACTION2013-04-23+$0$92,265RADIOPHARMACEUTICALS FOR THE BILOXI VA AND THE PENSACOLA JACC
Mod P00002· OTHER ADMINISTRATIVE ACTION2013-05-31+$90,632$182,897RADIOPHARMACEUTICALS FOR THE BILOXI VA AND THE PENSACOLA JACC
Mod P00003· EXERCISE AN OPTION2013-10-01+$60,000$242,897RADIOPHARMACEUTICALS FOR THE BILOXI VA AND THE PENSACOLA JACC - EXTEND SERVICES FROM 01 OCT 2013 - 31 DEC 2013
Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2014-02-05+$11,277$254,175RADIOPHARMACEUTICALS FOR THE BILOXI VA AND THE PENSACOLA JACC INCREASE FUNDS TO PAY FY 13 INVOICES
Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2014-02-13+$3,980$258,154RADIOPHARMACEUTICALS FOR THE BILOXI VA AND THE PENSACOLA JACC INCREASE FUNDS TO PAY FY 13 INVOICES
Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2014-05-08−$93$258,061RADIOPHARMACEUTICALS FOR THE BILOXI VA AND THE PENSACOLA JACC DECREASE FUNDS CREDITED BACK FOR CT CREDITS ON…
Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2014-05-16+$15,663$273,724RADIOPHARMACEUTICALS FOR THE BILOXI VA AND THE PENSACOLA JACC INCREASE FUNDS IN ORDER TO PAY FINAL INVOICES (…
Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2014-09-22+$1,009$274,733RADIOPHARMACEUTICALS FOR THE BILOXI VA AND THE PENSACOLA JACC INCREASE FUNDS IN ORDER TO PAY FINAL INVOICES (…

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NRMNYAAVZ767)

AwardOffice · PSC / listingNet obligationsFY
36C25522N0051255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$7,678FY2022
36C25521N0048255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$145,047FY2021
36C24120N0016241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS$368,096FY2020
36C25519N0519255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$134,688FY2019
36C24419P0012244-NETWORK CONTRACT OFFICE 4 (36C244) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$30,306FY2019
36C24819N0033248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$125,065FY2019

Other recipients under 6505 from 256-NETWORK CONTRACT OFFICE 16 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA25616P0619BIOCOMPATIBLES, INC.256-NETWORK CONTRACT OFFICE 16$147,500FY2016
VA25616F0536RETURNS 'R' US, LLC256-NETWORK CONTRACT OFFICE 16$0FY2016
VA25616E3628MCKESSON CORPORATION256-NETWORK CONTRACT OFFICE 16$17,878,985FY2016
VA25616P0541MCKESSON PLASMA AND BIOLOGICS LLC256-NETWORK CONTRACT OFFICE 16$10,851FY2016
VA25616P0522BIOCOMPATIBLES, INC.256-NETWORK CONTRACT OFFICE 16$32,000FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25613P0846_3600_-NONE-_-NONE- · retrieved 2026-09-26.